Advancing Inherited Retinal Disease Trials: Focus on Meaningful Outcomes for Patients
For individuals and families living with inherited retinal diseases (IRDs), the journey toward effective treatments is filled with hope and challenges. A recent article in Ophthalmology Times Europe, published on December 26, 2025, highlights a critical discussion among researchers: how to best measure the true impact of new therapies in clinical trials. This focus on
